Study of efficacy of miltefosine and allopurinol in dogs with leishmaniosis

Veterinary Journal

Volumn 182, Issue 3, 2009, Pages 441-445

  Manna, Laura ^a   Vitale, Fabrizio ^b   Reale, Stefano ^b   Picillo, Esther ^a   Neglia, Gianluca ^a   Vescio, Francesco ^c   Gravino, Angelo Elio ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLA SICILIA A MIRRI   (Italy)

^c Libero Professionista   (Italy)

Author keywords

Animal model; Dog; Leishmania; Miltefosine; Real time PCR; Therapy

Indexed keywords

ALLOPURINOL; MILTEFOSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DEATH; DOG DISEASE; DRUG EFFICACY; ERYTHROCYTE COUNT; FOLLOW UP; KIDNEY FAILURE; LEISHMANIA INFANTUM; LEUKOCYTE COUNT; LYMPH NODE BIOPSY; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NAUSEA; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; RELAPSE; VISCERAL LEISHMANIASIS; VOMITING;

ALLOPURINOL; ANIMALS; ANTIPROTOZOAL AGENTS; DISEASE MODELS, ANIMAL; DISEASE RESERVOIRS; DOG DISEASES; DOGS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; MALE; PHOSPHORYLCHOLINE; RECURRENCE; TREATMENT OUTCOME; ZOONOSES;

ANIMALIA; CANIS FAMILIARIS; HUMAN IMMUNODEFICIENCY VIRUS; LEISHMANIA INFANTUM;

EID: 71549118549     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2008.08.009     Document Type: Article

References (52)

1. Amato V.S., Tuon F.F., Siqueira A.M., Nicodemo A.C., and Neto V.A. Treatment of mucosal leishmaniasis in Latin America: systematic review. American Journal of Tropical Medicine and Hygiene 77 (2007) 266-274
2. Ashford R.W. Leishmaniasis reservoirs and their significance in control. Clinics in Dermatology 14 (1996) 523-532
3. Baneth G., and Shaw S.E. Chemotherapy of canine leishmaniosis. Veterinary Parasitology 106 (2002) 315-324
4. Bhattacharya S.K., Sinha P.K., Sundar S., Thakur C.P., Jha T.K., Pandey K., Das V.R., Kumar N., Lal C., Verma N., Singh V.P., Ranjan A., Verma R.B., Anders G., Sindermann H., and Ganguly N.K. Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis. The Journal of Infectious Diseases 196 (2007) 591-598
5. Brandão-Filho S.P., and Shaw J.J. Molecular tools versus parasite isolation for evaluating the hosts of Leishmania braziliensis. Trends in Parasitology 22 (2006) 500-501
6. Coutinho S.G., Pirmez C., and Da-Cruz A.M. Parasitological and immunological follow-up of American tegumentary leishmaniasis patients. Transactions and Royal Society of Tropical Medicine and Hygiene 96 (2002) S173-S178
7. Croft S.L., and Coombs G.H. Leishmaniasis - current chemotherapy and recent advances in the search novel drugs. Trends in Parasitology 19 (2003) 502-508
8. Croft S.L., Sundar S., and Fairlamb A.H. Drug resistance in leishmaniasis. Clinical Microbiology Reviews 19 (2006) 111-126
9. Dantas-Torres F., and Brandão-Filho S.P. Visceral leishmaniasis in Brazil: revisiting paradigms of epidemiology and control. Revista do Instituto de Medicina Tropical de Sao Paulo 48 (2006) 151-156
10. Denerolle P., and Bourdoiseau G. Combination allopurinol and antimony treatment versus antimony alone and allopurinol alone in the treatment of canine leishmaniosis (96 cases). Journal of Veterinary Internal Medicine 13 (1999) 413-415
11. Desjeux P. Leishmaniasis: current situation and new perspectives. Comparative Immunology, Microbiology and Infectious Disease 27 (2004) 305-318
12. Dorlo T.P., Eggelte T.A., Beijnen J.H., and de Vries P.J. Miltefosine: a new remedy for leishmaniasis. Nederlands Tijdschrift voor Geneeskunde 150 (2006) 2697-2701
13. Esfandiarpour I., Dabiri S.H., and Yousefi K. Dry type leishmanial lymphadenitis presented as two large parotid and cervical masses. International Journal of Dermatology 46 (2007) 711-714
14. Francino O., Altet L., Sanchez-Robert E., Rodriguez A., Solano-Gallego L., Alberola J., Ferrer L., Sanchez A., and Roura X. Advantages of real-time PCR assay for diagnosis and monitoring of canine leishmaniosis. Veterinary Parasitology 137 (2006) 214-221
15. Gramiccia M., and Gradoni L. The current status of zoonotic leishmaniases and approaches to disease control. International Journal for Parasitology 35 (2005) 1169-1180
16. Guerin P.J., Olliaro P., Sundar S., Boelaert M., Croft S.L., Desjeux P., Wasunna M.K., and Bryceson A.D. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. The Lancet, Infectious Diseases 2 (2002) 494-501
17. Ikonomopoulos J., Kokotas S., Gazouli M., Zavras A., Stoitsiou M., and Gorgoulis V.G. Molecular diagnosis of leishmaniosis in dogs. Comparative application of traditional diagnostic methods and the proposed assay on clinical samples. Veterinary Parasitology 113 (2003) 99-113
18. Koutinas A.F., Saridomichelakis M.N., Mylonakis M.E., Leontides L., Polizopoulou Z., Billinis C., Argyriadis D., Diakou N., and Papadopoulos O. A randomized, blinded, placebo-controlled clinical trial with allopurinol in canine leishmaniosis. Veterinary Parasitology 98 (2001) 247-261
19. Kuhlencord A., Maniera T., Eibl H., and Unger C. Hexadecylphosphocholine: oral treatment of visceral leishmaniasis in mice. Antimicrobial Agents and Chemotherapy 36 (1992) 1630-1634
20. Kumar R., Bumb R.A., Ansari N.A., Mehta R.D., and Salotra P. Cutaneous leishmaniasis caused by Leishmania tropica in Bikaner, India: parasite identification and characterization using molecular and immunologic tools. American Journal of Tropical Medicine and Hygiene 76 (2007) 896-901
21. Lainson R., and Rangel E.F. Lutzomyia longipalpis and the eco-epidemiology of American visceral leishmaniasis, with particular reference to Brazil: a review. Memorias do Instituto Oswaldo Cruz 100 (2005) 811-827
22. Maly K., Uberall F., Schubert C., Kindler E., Stekar J., Brachwitz H., and Grunicke H.H. Interference of new alkylphospholipid analogues with mitogenic signal transduction. Anti-cancer Drug Design 10 (1995) 411-425
23. Manna L., Vitale F., Reale S., Caracappa S., Pavone L.M., Della Morte R., Cringoli G., Staiano N., and Gravino A.E. Comparison of different tissue sampling for PCR-based diagnosis and follow-up of canine visceral leishmaniosis. Veterinary Parasitology 125 (2004) 251-262
24. Manna L., Reale S., Viola E., Vitale F., Manzillo V.F., Michele P.L., Caracappa S., and Gravino A.E. Leishmania DNA load and cytokine expression levels in asymptomatic naturally infected dogs. Veterinary Parasitology 142 (2006) 271-280
25. Manna L., Reale S., Picillo E., Vitale F., and Gravino A.E. Urine sampling for real-time polymerase chain reaction based diagnosis of canine leishmaniasis. Journal of Veterinary Diagnostic Investigation 20 (2008) 64-67
26. Manna L., Reale S., Vitale F., Picillo E., Pavone L.M., and Gravino A.E. Real-time PCR assay in Leishmania-infected dogs treated with meglumine antimoniate and allopurinol. The Veterinary Journal 177 (2008) 279-282
27. Martinez S., Looker D.L., Berens R.L., and Marr J.J. The synergistic action of pyrazolopyrimidines and pentavalent antimony against Leishmania donovani and L. braziliensis. American Journal of Tropical Medicine and Hygiene 39 (1988) 250-255
28. Mary C., Faraut F., Lascombe L., and Dumon H. Quantification of Leishmania infantum DNA by a real-time PCR assay with high sensitivity. Journal of Clinical Microbiology 42 (2004) 5249-5255
29. Mendonça M.G., de Brito M.E., Rodrigues E.H., Bandeira V., Jardim M.L., and Abath F.G. Persistence of Leishmania parasites in scars after clinical cure of American cutaneous leishmaniasis: is there a sterile cure?. The Journal of Infectious Diseases 189 (2004) 1018-1023
30. Mohebali M., Fotouhi A., Hooshmand B., Zarei Z., Akhoundi B., Rahnema A., Razaghian A.R., Kabir M.J., and Nadim A. Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran. Acta Tropica 103 (2007) 33-40
31. Moreno J., and Alvar J. Canine leishmaniasis: epidemiological risk and the experimental model. Trends in Parasitology 18 (2002) 399-405
32. Murray H.W. Clinical and experimental advances in the treatment of visceral leishmaniasis. Antimicrobial Agents and Chemotherapy 45 (2001) 2185-2197
33. Pratlong F., Rioux J.A., Marty P., Faraut-Gambarelli F., Dereure J., Lanotte G., and Dedet J.P. Isoenzymatic analysis of 712 strains of Leishmania infantum in the south of France and relationship of enzymatic polymorphism to clinical and epidemiological features. Journal of Clinical Microbiology 42 (2004) 4077-4082
34. Ramesh V., Kumar J., and Salotra P. An unusual presentation of post-kala-azar dermal leishmaniasis. Tropical Doctor 37 (2007) 172-173
35. Reithinger R., Espinoza J.C., Courtenay O., and Davies C.R. Evaluation of PCR as a diagnostic mass-screening tool to detect Leishmania (Viannia) spp. in domestic dogs (Canis familiaris). Journal of Clinical Microbiology 41 (2003) 1486-1493
36. Rolao N., Cortes S., Rodrigues O.R., and Ciampino L. Quantification of Leishmania infantum parasites in tissue biopsies by real-time polymerase chain reaction and polymerase chain reaction-enzyme-linked immunosorbent assay. Journal of Parasitology 90 (2004) 1150-1154
37. Sangraula H., Sharma K.K., Rijal S., Dwivedi S., and Koirala S. Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine. Journal of the Association of Physicians of India 51 (2003) 686-690
38. Saridomichelakis M.N., Mylonakis M.E., Leontides L.S., Billinis C., Koutinas A.F., Galatos A.D., Gouletsou P., Diakou A., and Kontos V.I. Periodic administration of allopurinol is not effective for the prevention of canine leishmaniosis (Leishmania infantum) in the endemic areas. Veterinary Parasitology 130 (2005) 199-205
39. Schubach A., Marzochi M.C., Cuzzi-Maya T., Oliveira A.V., Araujo M.L., Oliveira A.L., Pacheco R.S., Momen H., Conceicao-Silva F., Coutinho S.G., and Marzochi K.B. Cutaneous scars in American tegumentary leishmaniasis patients: a site of Leishmania (Viannia) braziliensis persistence and viability 11 years after antimonial therapy and clinical cure. American Journal of Tropical Medicine and Hygiene 58 (1998) 824-827
40. Sindermann H., Croft S.L., Engel K.R., Bommer W., Eibl H.J., Unger C., and Engel J. Miltefosine (Impavido): the first oral treatment against leishmaniasis. Medical Microbiology and Immunology 193 (2004) 173-180
41. Singh R., Kumar D., Ramesh V., Negi N.S., Singh S., and Salotra P. Visceral leishmaniasis, or kala azar (KA): high incidence of refractoriness to antimony is contributed by anthroponotic transmission via post-KA dermal leishmaniasis. The Journal of Infectious Diseases 194 (2006) 302-306
42. Soto J., and Toledo J.T. Oral miltefosine to treat new world cutaneous leishmaniasis. The Lancet, Infectious Diseases 7 (2007) 7
43. SPSS 12.0 User Guide, 2005. McGraw-Hill, New York.
44. Sundar S., and Rai M. Treatment of visceral leishmaniasis. Expert Opinion on Pharmacotherapy 6 (2005) 2821-2829
45. Sundar S., Rosenkaimer F., Makharia M.K., Goyal A.K., Mandal A.K., Voss A., Hilgard P., and Murray H.W. Trial of oral miltefosine for visceral leishmaniasis. Lancet 352 (1998) 1821-1823
46. Sundar S., Jha T.K., Thakur C.P., Engel J., Sindermann H., Fischer C., Junge K., Bryceson A., and Berman J. Oral miltefosine for Indian visceral leishmaniasis. New England Journal of Medicine 347 (2002) 1739-1746
47. Thakur C.P., Kumar A., Mitra G., Thakur S., and Thakur M. Pharmacovigilance in kala-azar patients with severe thrombocytopenia caused by sodium antimony gluconate and miltefosine. Indian Journal of Medicine Research 126 (2007) 73-75
48. Troya J., Casquero A., Refoyo E., Fernández-Guerrero M.L., and Górgolas M. Long term failure of miltefosine in the treatment of refractory visceral leishmaniasis in AIDS patients. Scandinavian Journal of Infectious Diseases 40 (2008) 78-80
49. Van der Meide W., Shoone G.J., Faber R.F., Zeegelaar J.E., de Vries H.J.C., Ozbel Y., and Shalling D.F. Quantitative nucleic acid sequence-based assay as a new molecular tool for detection and quantification of Leishmania parasites in skin biopsy samples. Journal of Clinical Microbiology 43 (2005) 5560-5566
50. Vercammen F., Fernandez-Perez F.J., del Amo C., and Alunna J.M. Follow-up of Leishmania infantum naturally infected dogs treated with allopurinol: immunofluorescence antibody test, ELISA and Western blot. Acta Tropica 84 (2002) 175-181
51. Verma N.K., and Dey C.S. Possible mechanism of miltefosine mediated death of Leishmania donovani. Antimicrobial Agents and Chemotherapy 48 (2004) 3010-3015
52. Zerpa O., Ulrich M., Blanco B., Polegre M., Avila A., Matos N., Mendoza I., Pratlong F., Ravel C., and Convit J. Diffuse cutaneous leishmaniasis responds to miltefosine but then relapses. The British Journal of Dermatology 156 (2007) 1328-1335